# Use of Belatacept to Delay Tacrolimus Initiation in Kidney Transplant Patients With Delayed Graft Function

> **NCT06091995** · — · COMPLETED · sponsor: **Methodist Health System** · enrollment: 67 (actual)

## Conditions studied

- Use of Belatacept in Kidney Transplant Patients

## Interventions

- **BEHAVIORAL:** impact of administering one dose of belatacept on Estimated Glomerular Filtration Rate(eGFR)

## Key facts

- **NCT ID:** NCT06091995
- **Lead sponsor:** Methodist Health System
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-22
- **Primary completion:** 2025-07-07
- **Final completion:** 2025-07-07
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06091995

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06091995, "Use of Belatacept to Delay Tacrolimus Initiation in Kidney Transplant Patients With Delayed Graft Function". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06091995. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*